Al-Shamali, Huda F.
Janssen-Aguilar, Reinhard
Hussaini, Amaan
Sharma, Vihaan
Elugot, Himanshi
Li, Xin
Jetly, Rakesh
Zhang, Yanbo
Tang, Victor
Jha, Manish K.
Bhat, Venkat
Article History
Received: 9 July 2025
Accepted: 8 September 2025
First Online: 24 September 2025
Declarations
:
: No animal or human subjects by the authors were used in this study.
: Dr. Victor Tang has received research support through the Brain & Behavior Research Foundation, Canadian Institutes of Health Research (SCT – 191291), the Physician Services Incorporated Foundation, the National Institute on Drug Abuse (R21DA061350), the CAMH Discovery Fund, the Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario, and the Labatt Family Network for Research on the Biology of Depression. Dr. Manish K. Jha reports receiving, in the past 24 months, contract research grants from Neurocrine Bioscience, Navitor/Supernus, and Janssen Research & Development; honoraria for serving as Section Editor of the Psychiatry & Behavioral Health Learning Network and Guest Editor for Psychiatric Clinics of North America (Elsevier); consulting fees from Janssen Scientific Affairs and Boehringer Ingelheim; fees for serving on Data Safety and Monitoring Boards for Worldwide Clinical Trials (Eliem and Inversago), Vicore Pharma, and IQVIA (Click); and honoraria for educational presentations from the North American Center for Continuing Medical Education, Medscape/WebMD, Clinical Care Options, Physicians’ Education Resource, and H.C. Wainwright & Co. Dr. Rakesh Jetly is the Chief Medical Officer of Mydecine Innovation Group. Dr. Venkat Bhat is supported by an Academic Scholar Award from the University of Toronto Department of Psychiatry and has received research funding from the Canadian Institutes of Health Research, Brain & Behavior Foundation, Ontario Ministry of Health Innovation Funds, Royal College of Physicians and Surgeons of Canada, Department of National Defence (Government of Canada), New Frontiers in Research Fund, Associated Medical Services Inc. Healthcare, American Foundation for Suicide Prevention, Roche Canada, Novartis, and Eisai. Dr. Yanbo Zhang is supported by the University of Alberta’s startup fund and has received research funding from the Canadian Institutes of Health Research, the Government of Alberta, Mitacs, and the New Frontiers in Research Fund. All remaining authors declare no conflicts of interest.